Annamycin Turns “Cold” Pancreatic Tumors “Hot” in New Preclinical Data Presented at AACR

Data presented at the AACR Conference on Pancreatic Cancer indicate Annamycin’s antitumor activity is partially mediated by CD8+ T cells, supporting a potential immune-mediated mechanism alongside its direct cytotoxic activityHOUSTON, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. NASDA…